Devices descending from DEN170058
6 later devices reach MSK-IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets):a… through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K260235 | CellDx-Tissue | Datar Cancer Genetics Private Limited | 2026 | 0 | — |
| +1 | K241868 | xR IVD | Tempus AI, Inc. | 2025 | 0 | — |
| +1 | K210017 | ACTOnco, ACTOnco IVD | Act Genomics | 2022 | 0 | — |
| +1 | K192063 | PGDx elio tissue complete | Personal Genome Diagnostics | 2020 | 1 | — |
| +1 | K190661 | Omics Core | Nanthealth, Inc. | 2019 | 0 | — |
| +2 | K250003 | GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005) | Geneseeq Technology, Inc. | 2025 | 0 | — |